Dr Reddy#39;s Labs Q3 preview: YoY rise in sales, profit expected; updates on niche ANDA filings, new launches to be in focus

Brokerage firm Kotak Institutional Equities expects the company#39;s US business to increase by $8 mn quarter-on-quarter (QoQ) to $255 mn, led by the launch of Kuvan.

from Moneycontrol Latest News https://ift.tt/3iUPk3I